A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis

NCT02279563 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

595

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Azelastine HCl and Fluticasone Propionate Nasal Spray, 137 µg/50 µg per spray
DRUG: Dymista™ Nasal Spray
DRUG: Placebo

Sponsor

Apotex Inc.